glp 1 and gip medication Science Behind Glucagon Receptor Agonists for Obesity Research | News & Announcements How GLP-1 medications are transforming

Highlights Apart from facilitating insulin secretion, additional effects of GLP-1 include anti-inflammation, neuro-protection, and reducing the accumulation of fat

On Monday morning, Novo Nordisk, the makers of the GLP-1 drug semaglutide (Ozempic and Wegovy), and Hims & Hers Health Inc

Nitric oxide sinthase in the human glaucomatous optic nerve head

Hanmi is pursuing expansion of efpeglenatides indications beyond obesity into diabetes, targeting obesity approval in the second half of 2026 and diabetes indications in 2028

That off switch often brings gut relief

Improves Blood Sugar: Regulates glucose levels and supports metabolic health